Business Description
Evogene Ltd
ISIN : IL0011050551
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.7 | |||||
Equity-to-Asset | 0.24 | |||||
Debt-to-Equity | 0.96 | |||||
Debt-to-EBITDA | -0.5 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -7 | |||||
Beneish M-Score | -0.79 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 49.6 | |||||
3-Year EBITDA Growth Rate | 14.8 | |||||
3-Year EPS without NRI Growth Rate | 14.1 | |||||
3-Year FCF Growth Rate | 11.9 | |||||
3-Year Book Growth Rate | -43.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.57 | |||||
9-Day RSI | 52.61 | |||||
14-Day RSI | 49.2 | |||||
6-1 Month Momentum % | 18.05 | |||||
12-1 Month Momentum % | 28.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.96 | |||||
Quick Ratio | 4.95 | |||||
Cash Ratio | 4.47 | |||||
Days Inventory | 68.82 | |||||
Days Sales Outstanding | 32.07 | |||||
Days Payable | 268.62 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.4 | |||||
Shareholder Yield % | -35.85 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70 | |||||
Operating Margin % | -469.99 | |||||
Net Margin % | -423.38 | |||||
FCF Margin % | -396.49 | |||||
ROE % | -125.85 | |||||
ROA % | -44.59 | |||||
ROIC % | -124.35 | |||||
ROC (Joel Greenblatt) % | -675.08 | |||||
ROCE % | -54.58 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6 | |||||
PB Ratio | 3.01 | |||||
EV-to-EBIT | -0.64 | |||||
EV-to-Forward-EBIT | -0.82 | |||||
EV-to-EBITDA | -0.71 | |||||
EV-to-Forward-EBITDA | -1.28 | |||||
EV-to-Revenue | 2.93 | |||||
EV-to-Forward-Revenue | 0.57 | |||||
EV-to-FCF | -0.75 | |||||
Price-to-Median-PS-Value | 0.26 | |||||
Earnings Yield (Greenblatt) % | -155.99 | |||||
FCF Yield % | -62.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Evogene Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 20.862 | ||
EPS (TTM) (₪) | -1.961 | ||
Beta | 0 | ||
Volatility % | 93.12 | ||
14-Day RSI | 49.2 | ||
14-Day ATR (₪) | 0.102551 | ||
20-Day SMA (₪) | 2.6072 | ||
12-1 Month Momentum % | 28.86 | ||
52-Week Range (₪) | 1.893 - 5 | ||
Shares Outstanding (Mil) | 50.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Evogene Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Evogene Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Evogene Ltd Frequently Asked Questions
What is Evogene Ltd(XTAE:EVGN)'s stock price today?
When is next earnings date of Evogene Ltd(XTAE:EVGN)?
Does Evogene Ltd(XTAE:EVGN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |